Previous studies have revealed that NOD1 contributes to tumour development and progression, particularly in CRC and gastric cancer, which originate in sites with high host‐microbiome interactions (Jiang et al., 2020; Maisonneuve et al., 2021; Wang, 2012). This evidence concerns the gene NOD1 and colorectal carcinoma.